Arecor Therapeutics plc

LSE AREC.L

Arecor Therapeutics plc Share Price on January 24, 2025: USD 0.73

Arecor Therapeutics plc Share Price is USD 0.73 on January 24, 2025, a -66.25% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Arecor Therapeutics plc 52-week high Share Price is USD 2.12 on February 01, 2024, which is 189.77% above the current Share Price.
  • Arecor Therapeutics plc 52-week low Share Price is USD 0.71 on January 17, 2025, which is -2.55% below the current Share Price.
  • Arecor Therapeutics plc average Share Price for the last 52 weeks is USD 1.36.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
SV Wall Street
LSE: AREC.L

Arecor Therapeutics plc

CEO Dr. Sarah Jennifer Howell Ph.D.
IPO Date June 3, 2021
Location United Kingdom
Headquarters Chesterford Research Park
Employees 50
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Similar companies

POLB.L

Poolbeg Pharma PLC

USD 0.07

-3.12%

StockViz Staff

January 30, 2025

Any question? Send us an email